FDA Guidance “Computer Software Assurance”

Groerilla Silverback Consulting

Expertise in MedTech – Unlock Innovation Today

Understanding the Latest FDA Guidance on Software Validation

On September 24, 2025, the FDA released its final guidance “Computer Software Assurance for Production and Quality System Software.” This new guidance builds upon established CSV principles while introducing more flexible, risk-based approaches specifically for production and quality system software.

Rather than replacing traditional GAMP 5 methods, the FDA guidance offers pragmatic extensions: high-risk functions maintain comprehensive validation while lower-risk applications can leverage vendor assessments and unscripted testing. The challenge for MedTech companies lies in understanding where each approach provides value and how to integrate them effectively.

To help visualize these concepts and their practical application, we’ve created a comprehensive comparison that maps traditional CSV practices against the new FDA recommendations. This interactive guide illustrates the overlap areas, key differences, and provides practical integration strategies for organizations looking to evolve their validation approaches while maintaining compliance.

Explore the visual comparison below to understand how GAMP 5 and FDA CSA can work together in your validation strategy.

FDA Computer Software Assurance vs CSV Concept

FDA Computer Software Assurance vs CSV Concept

Bridging Risk-Based Approaches for Production & Quality System Software

by Dr. Sebastian Grömminger, created with Claude AI Sonnet 4

🇺🇸 FDA Computer Software Assurance (CSA)
Risk-based, least-burdensome approach for production/quality software
  • Risk-based framework: Focus effort based on process risk to device safety/quality
  • Intended use driven: Validate software based on specific intended use in production/QS
  • Flexible testing: Scripted vs unscripted testing based on risk level
  • Least-burdensome: No more validation than necessary to address risk
  • Leverages vendor validation: Use supplier assessments and existing validation
  • Digital records preferred: System logs, audit trails over paper documentation
  • Continuous monitoring: Ongoing performance monitoring throughout lifecycle
🏭 Traditional CSV Concept
Structured validation approach based on GAMP 5 and V-Model
  • GAMP 5 categories: Systematic classification of software complexity
  • V-Model approach: Specification and verification in parallel phases
  • IQ/OQ/PQ phases: Installation, Operational, Performance Qualification
  • URS/FRS/DS: User Requirements, Functional Requirements, Design Specification
  • Traceability Matrix: End-to-end requirement traceability
  • Documented protocols: Formal test protocols and reports
  • Change control: Formal change management and revalidation
🔄 Integrated Risk-Based Framework
1
Identify Intended Use
Define software purpose in production/quality system
2
Risk Assessment
High vs. not-high process risk analysis
3
Select Assurance Activities
Commensurate with identified risk level
4
Execute & Document
Perform testing with appropriate evidence
5
Maintain Validated State
Ongoing monitoring and change control
🔴 High Process Risk
  • Maintains critical process parameters affecting device safety
  • Measures/inspects product with limited human review
  • Performs automated process corrections
  • Generates instructions for use/labeling
  • Automates safety-critical surveillance/trending
Assurance Level: Commensurate with medical device risk (detailed scripted testing, formal protocols)
🟢 Not High Process Risk
  • Collects/records data for monitoring purposes
  • CAPA routing and automated logging
  • Data management and organization
  • Supporting production/quality system
  • Automated calculations with human review
Assurance Level: Commensurate with process risk (unscripted testing, vendor assessment may suffice)
🧪 Testing Methods & Documentation
Scripted Testing
High Risk: Detailed test cases, step-by-step procedures, expected results, traceability
Documentation: Detailed protocols, test results, formal reports
Unscripted Testing
Lower Risk: Exploratory testing, scenario testing, error guessing
Documentation: Summary descriptions, issues found, conclusions
Vendor Assessment
All Levels: Development practices, certifications, quality management
Documentation: Vendor evaluation records, service agreements
Digital Evidence
Preferred: System logs, audit trails, automated test results
Documentation: Electronic records with integrity controls
🔗 GAMP 5 vs FDA CSA: Overlap & Extensions
GAMP 5
V-Model Lifecycle
IQ/OQ/PQ Phases
URS/FRS/DS Documentation
Traceability Matrix
Category-Based Classification (1-5)
Shared Concepts
Risk-Based Approach
Software Categorization
Testing Methods
Vendor Assessment
Change Control
Documentation Requirements
FDA CSA
Intended Use Focus
High vs Not-High Process Risk
Least-Burdensome Principle
Unscripted Testing Methods
Digital Evidence Preference
Continuous Performance Monitoring

GAMP 5 Traditional Strengths

  • Structured Categories: Clear 1-5 classification system based on software complexity and customization
  • V-Model Framework: Parallel specification and verification phases ensuring comprehensive coverage
  • Formal Qualification: IQ/OQ/PQ phases with detailed protocols and sign-offs
  • Requirements Traceability: End-to-end traceability from URS through testing
  • Industry Acceptance: Widely recognized and implemented across pharmaceutical/medical device industries

FDA CSA Extensions Beyond GAMP 5

  • Intended Use Granularity: Feature/function level analysis rather than whole system categorization
  • Binary Risk Classification: Simplified high/not-high process risk instead of complex RPZ calculations
  • Flexible Testing Approaches: Explicit endorsement of unscripted, exploratory, and scenario testing
  • Vendor Validation Leverage: Formal recognition of supplier testing and certifications
  • Agile-Compatible: Supports iterative development and continuous deployment practices
  • Digital-First Documentation: System logs and audit trails preferred over paper protocols
  • Continuous Assurance: Ongoing monitoring beyond traditional qualification phases

Want to learn more about actionable Computer Software Validation concepts?

Contact me here:

Groerilla.com | Dr. Sebastian Grömminger